A retrospective,cross sectional study to evaluation of the effects of deviations from a regular dosing schedule on glycemic control and hypoglycemia and overweight on patients with Diabetes Mellitus treated with Insulin glargine and Insulin degludec

Trial Profile

A retrospective,cross sectional study to evaluation of the effects of deviations from a regular dosing schedule on glycemic control and hypoglycemia and overweight on patients with Diabetes Mellitus treated with Insulin glargine and Insulin degludec

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 May 2017

At a glance

  • Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 May 2017 New trial record
    • 01 Apr 2017 Results published in the Diabetes Therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top